Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Diabetes

  Free Subscription


Articles published in Invest Ophthalmol Vis Sci

Retrieve available abstracts of 80 articles:
HTML format
Text format



Single Articles


    April 2019
  1. FIGUERAS-ROCA M, Sala-Puigdollers A, Zarranz-Ventura J, Alba-Linero C, et al
    Anatomic Response to Intravitreal Dexamethasone Implant and Baseline Aqueous Humor Cytokine Levels in Diabetic Macular Edema.
    Invest Ophthalmol Vis Sci. 2019;60:1336-1343.
    PubMed     Text format     Abstract available


  2. BINOTTI WW, Romano AC
    Projection-Resolved Optical Coherence Tomography Angiography Parameters to Determine Severity in Diabetic Retinopathy.
    Invest Ophthalmol Vis Sci. 2019;60:1321-1327.
    PubMed     Text format     Abstract available


  3. MORINO K, Murakami T, Dodo Y, Yasukura S, et al
    Characteristics of Diabetic Capillary Nonperfusion in Macular and Extramacular White Spots on Optical Coherence Tomography Angiography.
    Invest Ophthalmol Vis Sci. 2019;60:1595-1603.
    PubMed     Text format     Abstract available


  4. CUI RZ, Wang L, Qiao SN, Wang YC, et al
    ON-Type Retinal Ganglion Cells are Preferentially Affected in STZ-Induced Diabetic Mice.
    Invest Ophthalmol Vis Sci. 2019;60:1644-1656.
    PubMed     Text format     Abstract available


  5. LIU H, Tang J, Du Y, Saadane A, et al
    Transducin1, Phototransduction and the Development of Early Diabetic Retinopathy.
    Invest Ophthalmol Vis Sci. 2019;60:1538-1546.
    PubMed     Text format     Abstract available


    March 2019
  6. ARCADU F, Benmansour F, Maunz A, Michon J, et al
    Deep Learning Predicts OCT Measures of Diabetic Macular Thickening From Color Fundus Photographs.
    Invest Ophthalmol Vis Sci. 2019;60:852-857.
    PubMed     Text format     Abstract available


  7. LI T, Jia Y, Wang S, Wang A, et al
    Retinal Microvascular Abnormalities in Children with Type 1 Diabetes Mellitus Without Visual Impairment or Diabetic Retinopathy.
    Invest Ophthalmol Vis Sci. 2019;60:990-998.
    PubMed     Text format     Abstract available


    February 2019
  8. CUI Y, Yang X, Zhang G, Guo H, et al
    Intraocular Pressure in General and Diabetic Populations From Southern China: the Dongguan Eye Study.
    Invest Ophthalmol Vis Sci. 2019;60:761-769.
    PubMed     Text format     Abstract available


  9. ESHAQ RS, Harris NR
    Loss of Platelet Endothelial Cell Adhesion Molecule-1 (PECAM-1) in the Diabetic Retina: Role of Matrix Metalloproteinases.
    Invest Ophthalmol Vis Sci. 2019;60:748-760.
    PubMed     Text format     Abstract available


  10. DMITRIEV AV, Henderson D, Linsenmeier RA
    Diabetes Alters pH Control in Rat Retina.
    Invest Ophthalmol Vis Sci. 2019;60:723-730.
    PubMed     Text format     Abstract available


  11. DEAK EA, Szalai E, Toth N, Malik RA, et al
    Longitudinal Changes in Corneal Cell and Nerve Fiber Morphology in Young Patients with Type 1 Diabetes with and without Diabetic Retinopathy: A 2-Year Follow-up Study.
    Invest Ophthalmol Vis Sci. 2019;60:830-837.
    PubMed     Text format     Abstract available


  12. SERGEYS J, Etienne I, Van Hove I, Lefevere E, et al
    Longitudinal In Vivo Characterization of the Streptozotocin-Induced Diabetic Mouse Model: Focus on Early Inner Retinal Responses.
    Invest Ophthalmol Vis Sci. 2019;60:807-822.
    PubMed     Text format     Abstract available


  13. YOSHITAKE T, Murakami T, Yoshitake S, Suzuma K, et al
    Anti-Fumarase Antibody as a Predictor of Functional Efficacy of Anti-VEGF Therapy for Diabetic Macular Edema.
    Invest Ophthalmol Vis Sci. 2019;60:787-794.
    PubMed     Text format     Abstract available


    January 2019
  14. HU J, Hu X, Kan T
    MiR-34c Participates in Diabetic Corneal Neuropathy Via Regulation of Autophagy.
    Invest Ophthalmol Vis Sci. 2019;60:16-25.
    PubMed     Text format     Abstract available


  15. ALAMRI AS, Brock JA, Herath CB, Rajapaksha IG, et al
    The Effects of Diabetes and High-Fat Diet on Polymodal Nociceptor and Cold Thermoreceptor Nerve Terminal Endings in the Corneal Epithelium.
    Invest Ophthalmol Vis Sci. 2019;60:209-217.
    PubMed     Text format     Abstract available


  16. ALLEN RS, Feola A, Motz CT, Ottensmeyer AL, et al
    Retinal Deficits Precede Cognitive and Motor Deficits in a Rat Model of Type II Diabetes.
    Invest Ophthalmol Vis Sci. 2019;60:123-133.
    PubMed     Text format     Abstract available


  17. MCANANY JJ, Park JC
    Cone Photoreceptor Dysfunction in Early-Stage Diabetic Retinopathy: Association Between the Activation Phase of Cone Phototransduction and the Flicker Electroretinogram.
    Invest Ophthalmol Vis Sci. 2019;60:64-72.
    PubMed     Text format     Abstract available


    December 2018
  18. HAFNER J, Salas M, Scholda C, Vogl WD, et al
    Dynamic Changes of Retinal Microaneurysms in Diabetes Imaged With In Vivo Adaptive Optics Optical Coherence Tomography.
    Invest Ophthalmol Vis Sci. 2018;59:5932-5940.
    PubMed     Text format     Abstract available


  19. OZAKI K, Terayama Y, Matsuura T
    Extended Duration of Hyperglycemia Result in Human-Like Corneal Nerve Lesions in Mice With Alloxan- and Streptozotocin-Induced Type 1 Diabetes.
    Invest Ophthalmol Vis Sci. 2018;59:5868-5875.
    PubMed     Text format     Abstract available


  20. SONG B, Kim D, Nguyen NH, Roy S, et al
    Inhibition of Diabetes-Induced Lysyl Oxidase Overexpression Prevents Retinal Vascular Lesions Associated With Diabetic Retinopathy.
    Invest Ophthalmol Vis Sci. 2018;59:5965-5972.
    PubMed     Text format     Abstract available


  21. YASUKURA S, Murakami T, Suzuma K, Yoshitake T, et al
    Diabetic Nonperfused Areas in Macular and Extramacular Regions on Wide-Field Optical Coherence Tomography Angiography.
    Invest Ophthalmol Vis Sci. 2018;59:5893-5903.
    PubMed     Text format     Abstract available


    November 2018
  22. JOLTIKOV KA, Sesi CA, de Castro VM, Davila JR, et al
    Disorganization of Retinal Inner Layers (DRIL) and Neuroretinal Dysfunction in Early Diabetic Retinopathy.
    Invest Ophthalmol Vis Sci. 2018;59:5481-5486.
    PubMed     Text format     Abstract available


  23. LIM SW, Bandala-Sanchez E, Kolic M, Rogers SL, et al
    The Influence of Intravitreal Ranibizumab on Inflammation-associated Cytokine Concentrations in Eyes With Diabetic Macular Edema.
    Invest Ophthalmol Vis Sci. 2018;59:5382-5390.
    PubMed     Text format     Abstract available


  24. LEE H, Chung H
    Author Response: Hyperreflective Intraretinal Foci as an OCT Biomarker of Retinal Inflammation in Diabetic Macular Edema.
    Invest Ophthalmol Vis Sci. 2018;59:5367.
    PubMed     Text format    


  25. MIDENA E, Pilotto E, Bini S
    Hyperreflective Intraretinal Foci as an OCT Biomarker of Retinal Inflammation in Diabetic Macular Edema.
    Invest Ophthalmol Vis Sci. 2018;59:5366.
    PubMed     Text format    


  26. LAMMER J, Karst SG, Lin MM, Cheney M, et al
    Association of Microaneurysms on Adaptive Optics Scanning Laser Ophthalmoscopy With Surrounding Neuroretinal Pathology and Visual Function in Diabetes.
    Invest Ophthalmol Vis Sci. 2018;59:5633-5640.
    PubMed     Text format     Abstract available


  27. YOU ZP, Zhang YL, Li BY, Zhu XG, et al
    Bioinformatics Analysis of Weighted Genes in Diabetic Retinopathy.
    Invest Ophthalmol Vis Sci. 2018;59:5558-5563.
    PubMed     Text format     Abstract available


  28. FERDOUSI M, Petropoulos IN, Kalteniece A, Azmi S, et al
    No Relation Between the Severity of Corneal Nerve, Epithelial, and Keratocyte Cell Morphology With Measures of Dry Eye Disease in Type 1 Diabetes.
    Invest Ophthalmol Vis Sci. 2018;59:5525-5530.
    PubMed     Text format     Abstract available


    October 2018
  29. VUJOSEVIC S, Muraca A, Gatti V, Masoero L, et al
    Peripapillary Microvascular and Neural Changes in Diabetes Mellitus: An OCT-Angiography Study.
    Invest Ophthalmol Vis Sci. 2018;59:5074-5081.
    PubMed     Text format     Abstract available


  30. JIN G, Xiao W, Ding X, Xu X, et al
    Prevalence of and Risk Factors for Diabetic Retinopathy in a Rural Chinese Population: The Yangxi Eye Study.
    Invest Ophthalmol Vis Sci. 2018;59:5067-5073.
    PubMed     Text format     Abstract available


  31. MCANANY JJ, Park JC
    Temporal Frequency Abnormalities in Early-Stage Diabetic Retinopathy Assessed by Electroretinography.
    Invest Ophthalmol Vis Sci. 2018;59:4871-4879.
    PubMed     Text format     Abstract available


  32. DURAISAMY AJ, Mishra M, Kowluru A, Kowluru RA, et al
    Epigenetics and Regulation of Oxidative Stress in Diabetic Retinopathy.
    Invest Ophthalmol Vis Sci. 2018;59:4831-4840.
    PubMed     Text format     Abstract available


    August 2018
  33. WANG N, Zou C, Zhao S, Wang Y, et al
    Fenofibrate Exerts Protective Effects in Diabetic Retinopathy via Inhibition of the ANGPTL3 Pathway.
    Invest Ophthalmol Vis Sci. 2018;59:4210-4217.
    PubMed     Text format     Abstract available


  34. ASHRAF M, Nesper PL, Jampol LM, Yu F, et al
    Statistical Model of Optical Coherence Tomography Angiography Parameters That Correlate With Severity of Diabetic Retinopathy.
    Invest Ophthalmol Vis Sci. 2018;59:4292-4298.
    PubMed     Text format     Abstract available


  35. NICHOLSON L, Crosby-Nwaobi R, Vasconcelos JC, Prevost AT, et al
    Mechanistic Evaluation of Panretinal Photocoagulation Versus Aflibercept in Proliferative Diabetic Retinopathy: CLARITY Substudy.
    Invest Ophthalmol Vis Sci. 2018;59:4277-4284.
    PubMed     Text format     Abstract available


    July 2018
  36. KALTENIECE A, Ferdousi M, Azmi S, Marshall A, et al
    Keratocyte Density Is Reduced and Related to Corneal Nerve Damage in Diabetic Neuropathy.
    Invest Ophthalmol Vis Sci. 2018;59:3584-3590.
    PubMed     Text format     Abstract available


    June 2018
  37. SANDHU HS, Eltanboly A, Shalaby A, Keynton RS, et al
    Automated Diagnosis and Grading of Diabetic Retinopathy Using Optical Coherence Tomography.
    Invest Ophthalmol Vis Sci. 2018;59:3155-3160.
    PubMed     Text format     Abstract available


    May 2018
  38. LU Y, Simonett JM, Wang J, Zhang M, et al
    Evaluation of Automatically Quantified Foveal Avascular Zone Metrics for Diagnosis of Diabetic Retinopathy Using Optical Coherence Tomography Angiography.
    Invest Ophthalmol Vis Sci. 2018;59:2212-2221.
    PubMed     Text format     Abstract available


  39. GALE JD, Berger B, Gilbert S, Popa S, et al
    A CCR2/5 Inhibitor, PF-04634817, Is Inferior to Monthly Ranibizumab in the Treatment of Diabetic Macular Edema.
    Invest Ophthalmol Vis Sci. 2018;59:2659-2669.
    PubMed     Text format     Abstract available


  40. MCANANY JJ, Park JC
    Reduced Contrast Sensitivity is Associated With Elevated Equivalent Intrinsic Noise in Type 2 Diabetics Who Have Mild or No Retinopathy.
    Invest Ophthalmol Vis Sci. 2018;59:2652-2658.
    PubMed     Text format     Abstract available


  41. LIM RR, Grant DG, Olver TD, Padilla J, et al
    Young Ossabaw Pigs Fed a Western Diet Exhibit Early Signs of Diabetic Retinopathy.
    Invest Ophthalmol Vis Sci. 2018;59:2325-2338.
    PubMed     Text format     Abstract available


  42. SUNDSTROM JM, Hernandez C, Weber SR, Zhao Y, et al
    Proteomic Analysis of Early Diabetic Retinopathy Reveals Mediators of Neurodegenerative Brain Diseases.
    Invest Ophthalmol Vis Sci. 2018;59:2264-2274.
    PubMed     Text format     Abstract available


    April 2018
  43. CHEN Q, Tan F, Wu Y, Zhuang X, et al
    Characteristics of Retinal Structural and Microvascular Alterations in Early Type 2 Diabetic Patients.
    Invest Ophthalmol Vis Sci. 2018;59:2110-2118.
    PubMed     Text format     Abstract available


  44. NAHOMI RB, Sampathkumar S, Myers AM, Elghazi L, et al
    The Absence of Indoleamine 2,3-Dioxygenase Inhibits Retinal Capillary Degeneration in Diabetic Mice.
    Invest Ophthalmol Vis Sci. 2018;59:2042-2053.
    PubMed     Text format     Abstract available


  45. LEI J, Yi E, Suo Y, Chen C, et al
    Distinctive Analysis of Macular Superficial Capillaries and Large Vessels Using Optical Coherence Tomographic Angiography in Healthy and Diabetic Eyes.
    Invest Ophthalmol Vis Sci. 2018;59:1937-1943.
    PubMed     Text format     Abstract available


  46. LUO XY, Tan NYQ, Chee ML, Shi Y, et al
    Direct and Indirect Associations Between Diabetes and Intraocular Pressure: The Singapore Epidemiology of Eye Diseases Study.
    Invest Ophthalmol Vis Sci. 2018;59:2205-2211.
    PubMed     Text format     Abstract available


  47. ONISHI AC, Nesper PL, Roberts PK, Moharram GA, et al
    Importance of Considering the Middle Capillary Plexus on OCT Angiography in Diabetic Retinopathy.
    Invest Ophthalmol Vis Sci. 2018;59:2167-2176.
    PubMed     Text format     Abstract available


    March 2018
  48. SCHORI C, Trachsel C, Grossmann J, Zygoula I, et al
    The Proteomic Landscape in the Vitreous of Patients With Age-Related and Diabetic Retinal Disease.
    Invest Ophthalmol Vis Sci. 2018;59:AMD31-AMD40.
    PubMed     Text format     Abstract available


  49. GLASSMAN AR, Liu D, Jampol LM, Sun JK, et al
    Changes in Blood Pressure and Urine Albumin-Creatinine Ratio in a Randomized Clinical Trial Comparing Aflibercept, Bevacizumab, and Ranibizumab for Diabetic Macular Edema.
    Invest Ophthalmol Vis Sci. 2018;59:1199-1205.
    PubMed     Text format     Abstract available


    February 2018
  50. DELIYANTI D, Alrashdi SF, Tan SM, Meyer C, et al
    Nrf2 Activation Is a Potential Therapeutic Approach to Attenuate Diabetic Retinopathy.
    Invest Ophthalmol Vis Sci. 2018;59:815-825.
    PubMed     Text format     Abstract available


  51. LEE H, Jang H, Choi YA, Kim HC, et al
    Association Between Soluble CD14 in the Aqueous Humor and Hyperreflective Foci on Optical Coherence Tomography in Patients With Diabetic Macular Edema.
    Invest Ophthalmol Vis Sci. 2018;59:715-721.
    PubMed     Text format     Abstract available


  52. CHEN H, Zhang X, Liao N, Mi L, et al
    Enhanced Expression of NLRP3 Inflammasome-Related Inflammation in Diabetic Retinopathy.
    Invest Ophthalmol Vis Sci. 2018;59:978-985.
    PubMed     Text format     Abstract available


  53. CHEN X, Graham J, Petropoulos IN, Ponirakis G, et al
    Corneal Nerve Fractal Dimension: A Novel Corneal Nerve Metric for the Diagnosis of Diabetic Sensorimotor Polyneuropathy.
    Invest Ophthalmol Vis Sci. 2018;59:1113-1118.
    PubMed     Text format     Abstract available


    January 2018
  54. WHITCUP SM, Cidlowski JA, Csaky KG, Ambati J, et al
    Pharmacology of Corticosteroids for Diabetic Macular Edema.
    Invest Ophthalmol Vis Sci. 2018;59:1-12.
    PubMed     Text format     Abstract available


  55. KIM MK, Aung MH, Mees L, Olson DE, et al
    Dopamine Deficiency Mediates Early Rod-Driven Inner Retinal Dysfunction in Diabetic Mice.
    Invest Ophthalmol Vis Sci. 2018;59:572-581.
    PubMed     Text format     Abstract available


  56. ABRAMOFF MD, Fort PE, Han IC, Jayasundera KT, et al
    Approach for a Clinically Useful Comprehensive Classification of Vascular and Neural Aspects of Diabetic Retinal Disease.
    Invest Ophthalmol Vis Sci. 2018;59:519-527.
    PubMed     Text format     Abstract available


    December 2017
  57. STUARD WL, Titone R, Robertson DM
    Tear Levels of Insulin-Like Growth Factor Binding Protein 3 Correlate With Subbasal Nerve Plexus Changes in Patients With Type 2 Diabetes Mellitus.
    Invest Ophthalmol Vis Sci. 2017;58:6105-6112.
    PubMed     Text format     Abstract available


  58. LAGALI NS, Allgeier S, Guimaraes P, Badian RA, et al
    Reduced Corneal Nerve Fiber Density in Type 2 Diabetes by Wide-Area Mosaic Analysis.
    Invest Ophthalmol Vis Sci. 2017;58:6318-6327.
    PubMed     Text format     Abstract available


  59. GUYON B, Elphege E, Flores M, Gauthier AS, et al
    Retinal Reflectivity Measurement for Cone Impairment Estimation and Visual Assessment After Diabetic Macular Edema Resolution (RECOVER-DME).
    Invest Ophthalmol Vis Sci. 2017;58:6241-6247.
    PubMed     Text format     Abstract available


  60. DURAISAMY AJ, Mishra M, Kowluru RA
    Crosstalk Between Histone and DNA Methylation in Regulation of Retinal Matrix Metalloproteinase-9 in Diabetes.
    Invest Ophthalmol Vis Sci. 2017;58:6440-6448.
    PubMed     Text format     Abstract available


  61. FENWICK EK, Khadka J, Pesudovs K, Rees G, et al
    Diabetic Retinopathy and Macular Edema Quality-of-Life Item Banks: Development and Initial Evaluation Using Computerized Adaptive Testing.
    Invest Ophthalmol Vis Sci. 2017;58:6379-6387.
    PubMed     Text format     Abstract available


  62. SRINIVASAN S, Dehghani C, Pritchard N, Edwards K, et al
    Corneal and Retinal Neuronal Degeneration in Early Stages of Diabetic Retinopathy.
    Invest Ophthalmol Vis Sci. 2017;58:6365-6373.
    PubMed     Text format     Abstract available


  63. ZHANG SJ, Chen X, Li CP, Li XM, et al
    Identification and Characterization of Circular RNAs as a New Class of Putative Biomarkers in Diabetes Retinopathy.
    Invest Ophthalmol Vis Sci. 2017;58:6500-6509.
    PubMed     Text format     Abstract available


  64. MITCHELL SL, Neininger AC, Bruce CN, Chocron IM, et al
    Mitochondrial Haplogroups Modify the Effect of Diabetes Duration and HbA1c on Proliferative Diabetic Retinopathy Risk in Patients With Type 2 Diabetes.
    Invest Ophthalmol Vis Sci. 2017;58:6481-6488.
    PubMed     Text format     Abstract available


    November 2017
  65. WEI Q, Zhang T, Jiang R, Chang Q, et al
    Vitreous Fibronectin and Fibrinogen Expression Increased in Eyes With Proliferative Diabetic Retinopathy After Intravitreal Anti-VEGF Therapy.
    Invest Ophthalmol Vis Sci. 2017;58:5783-5791.
    PubMed     Text format     Abstract available


  66. DODO Y, Murakami T, Suzuma K, Yoshitake S, et al
    Diabetic Neuroglial Changes in the Superficial and Deep Nonperfused Areas on Optical Coherence Tomography Angiography.
    Invest Ophthalmol Vis Sci. 2017;58:5870-5879.
    PubMed     Text format     Abstract available


  67. SRINIVASAN S, Raman R, Swaminathan G, Ganesan S, et al
    Incidence, Progression, and Risk Factors for Cataract in Type 2 Diabetes.
    Invest Ophthalmol Vis Sci. 2017;58:5921-5929.
    PubMed     Text format     Abstract available


  68. HWANG HS, Chae JB, Kim JY, Kim DY, et al
    Association Between Hyperreflective Dots on Spectral-Domain Optical Coherence Tomography in Macular Edema and Response to Treatment.
    Invest Ophthalmol Vis Sci. 2017;58:5958-5967.
    PubMed     Text format     Abstract available


    October 2017
  69. OMAE T, Nagaoka T, Yoshida A
    Effect of Circulating Omentin-1 on the Retinal Circulation in Patients With Type 2 Diabetes Mellitus.
    Invest Ophthalmol Vis Sci. 2017;58:5086-5092.
    PubMed     Text format     Abstract available


  70. HU P, Hunt NH, Arfuso F, Shaw LC, et al
    Increased Indoleamine 2,3-Dioxygenase and Quinolinic Acid Expression in Microglia and Muller Cells of Diabetic Human and Rodent Retina.
    Invest Ophthalmol Vis Sci. 2017;58:5043-5055.
    PubMed     Text format     Abstract available


  71. DENG G, Moran EP, Cheng R, Matlock G, et al
    Therapeutic Effects of a Novel Agonist of Peroxisome Proliferator-Activated Receptor Alpha for the Treatment of Diabetic Retinopathy.
    Invest Ophthalmol Vis Sci. 2017;58:5030-5042.
    PubMed     Text format     Abstract available


  72. BOSS JD, Singh PK, Pandya HK, Tosi J, et al
    Assessment of Neurotrophins and Inflammatory Mediators in Vitreous of Patients With Diabetic Retinopathy.
    Invest Ophthalmol Vis Sci. 2017;58:5594-5603.
    PubMed     Text format     Abstract available


  73. BLAIR NP, Wanek J, Felder AE, Joslin CE, et al
    Retinal Oximetry and Vessel Diameter Measurements With a Commercially Available Scanning Laser Ophthalmoscope in Diabetic Retinopathy.
    Invest Ophthalmol Vis Sci. 2017;58:5556-5563.
    PubMed     Text format     Abstract available


  74. HAFNER J, Ginner L, Karst S, Leitgeb R, et al
    Regional Patterns of Retinal Oxygen Saturation and Microvascular Hemodynamic Parameters Preceding Retinopathy in Patients With Type II Diabetes.
    Invest Ophthalmol Vis Sci. 2017;58:5541-5547.
    PubMed     Text format     Abstract available


    September 2017
  75. DI G, Qi X, Zhao X, Zhang S, et al
    Corneal Epithelium-Derived Neurotrophic Factors Promote Nerve Regeneration.
    Invest Ophthalmol Vis Sci. 2017;58:4695-4702.
    PubMed     Text format     Abstract available


  76. FERNANDEZ-BUENO I, Jones R, Soriano-Romani L, Lopez-Garcia A, et al
    Histologic Characterization of Retina Neuroglia Modifications in Diabetic Zucker Diabetic Fatty Rats.
    Invest Ophthalmol Vis Sci. 2017;58:4925-4933.
    PubMed     Text format     Abstract available


  77. KAIZU Y, Nakao S, Yoshida S, Hayami T, et al
    Optical Coherence Tomography Angiography Reveals Spatial Bias of Macular Capillary Dropout in Diabetic Retinopathy.
    Invest Ophthalmol Vis Sci. 2017;58:4889-4897.
    PubMed     Text format     Abstract available


  78. BRAZIER J, Muston D, Konwea H, Power GS, et al
    Evaluating the Relationship Between Visual Acuity and Utilities in Patients With Diabetic Macular Edema Enrolled in Intravitreal Aflibercept Studies.
    Invest Ophthalmol Vis Sci. 2017;58:4818-4825.
    PubMed     Text format     Abstract available


    May 2017
  79. JOLTIKOV KA, de Castro VM, Davila JR, Anand R, et al
    Multidimensional Functional and Structural Evaluation Reveals Neuroretinal Impairment in Early Diabetic Retinopathy.
    Invest Ophthalmol Vis Sci. 2017;58:BIO277-BIO290.
    PubMed     Text format     Abstract available


  80. NESPER PL, Roberts PK, Onishi AC, Chai H, et al
    Quantifying Microvascular Abnormalities With Increasing Severity of Diabetic Retinopathy Using Optical Coherence Tomography Angiography.
    Invest Ophthalmol Vis Sci. 2017;58:BIO307-BIO315.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Diabetes is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: